192 related articles for article (PubMed ID: 29757495)
1. A 20-year and 46,000-specimen journey to Paris reveals the influence of reporting systems and passive peer feedback on pathologist practice patterns.
VandenBussche CJ; Allison DB; Gupta M; Ali SZ; Rosenthal DL
Cancer Cytopathol; 2018 Jun; 126(6):381-389. PubMed ID: 29757495
[TBL] [Abstract][Full Text] [Related]
2. One year of experience using the Paris System for Reporting Urinary Cytology.
Meilleroux J; Daniel G; Aziza J; d'Aure DM; Quintyn-Ranty ML; Basset CM; Evrard SM; Courtade-Saidi MM
Cancer Cytopathol; 2018 Jun; 126(6):430-436. PubMed ID: 29663682
[TBL] [Abstract][Full Text] [Related]
3. Improved correlation of urinary cytology specimens using The Paris System in biopsy-proven upper tract urothelial carcinomas.
McIntire PJ; Snow JT; Robinson BD; Rao RA; Goyal A; Heymann JJ; Siddiqui MT
Cancer Cytopathol; 2018 Jul; 126(7):498-504. PubMed ID: 29927548
[TBL] [Abstract][Full Text] [Related]
4. Improved diagnostic precision of urine cytology by implementation of The Paris System and the use of cell blocks.
Chan E; Balassanian R; Tabatabai ZL; Lou H; Vohra P
Cancer Cytopathol; 2018 Sep; 126(9):809-816. PubMed ID: 30203925
[TBL] [Abstract][Full Text] [Related]
5. Improved risk stratification for patients with high-grade urothelial carcinoma following application of the Paris System for Reporting Urinary Cytology.
Cowan ML; Rosenthal DL; VandenBussche CJ
Cancer Cytopathol; 2017 Jun; 125(6):427-434. PubMed ID: 28272842
[TBL] [Abstract][Full Text] [Related]
6. Should the BK polyomavirus cytopathic effect be best classified as atypical or benign in urine cytology specimens?
Allison DB; Olson MT; Lilo M; Zhang ML; Rosenthal DL; VandenBussche CJ
Cancer Cytopathol; 2016 Jun; 124(6):436-42. PubMed ID: 26929126
[TBL] [Abstract][Full Text] [Related]
7. Comparison between cytospin and liquid-based cytology in urine specimens classified according to the Paris System for Reporting Urinary Cytology.
Straccia P; Bizzarro T; Fadda G; Pierconti F
Cancer Cytopathol; 2016 Jul; 124(7):519-23. PubMed ID: 26989867
[TBL] [Abstract][Full Text] [Related]
8. Cytologic evaluation of upper urinary tract specimens: An institutional retrospective study using The Paris System for Reporting Urine Cytology second edition with histopathologic follow-up.
Khajir G; Sun T; Wang H; Sprenkle PC; Adeniran AJ; Cai G; Levi AW
Cytopathology; 2024 Mar; 35(2):235-241. PubMed ID: 37916579
[TBL] [Abstract][Full Text] [Related]
9. Effect of the Paris system for reporting urinary cytology with histologic follow-up.
Rohra P; Ocampo Gonzalez FA; Yan L; Mir F; Furlan K; Basu S; Barua A; Cheng L; Park JW
Diagn Cytopathol; 2021 Jun; 49(6):691-699. PubMed ID: 33600080
[TBL] [Abstract][Full Text] [Related]
10. Comparison of urine cytology diagnostic reports before and after the implementation of the Paris System classification system in China.
Ma C; Zhang L
Cytopathology; 2020 Sep; 31(5):457-462. PubMed ID: 32246545
[TBL] [Abstract][Full Text] [Related]
11. Applying the Paris system for reporting urine cytology to challenging cytology cases.
Glass R; Rosca O; Raab S; Szabelska J; Chau K; Sheikh-Fayyaz S; Cocker R
Diagn Cytopathol; 2019 Jul; 47(7):675-681. PubMed ID: 31017746
[TBL] [Abstract][Full Text] [Related]
12. Impact of Implementing the Paris System for Reporting Urinary Cytology: A Single-institutional Experience With Emphasis on Diagnostic Yield of High-grade Urothelial Carcinoma and Low-grade Urothelial Neoplasm.
Koh HH; Lee MJ; Park NJ; Kim HS; Oh YL
Anticancer Res; 2020 Jun; 40(6):3477-3484. PubMed ID: 32487647
[TBL] [Abstract][Full Text] [Related]
13. Atypical Category of the Johns Hopkins Template Has Higher Risk of Malignancy than the Paris System but the Paris System Is More Applicable for Suspicious Category.
Celik B; Kavas G
Acta Cytol; 2023; 67(4):425-433. PubMed ID: 36731438
[TBL] [Abstract][Full Text] [Related]
14. The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology.
Barkan GA; Wojcik EM; Nayar R; Savic-Prince S; Quek ML; Kurtycz DF; Rosenthal DL
Adv Anat Pathol; 2016 Jul; 23(4):193-201. PubMed ID: 27233050
[TBL] [Abstract][Full Text] [Related]
15. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
[TBL] [Abstract][Full Text] [Related]
16. The utility of upper urinary tract urine cytology before and after application of the Paris system.
Simon CT; Skala SL; Magers MJ; Weizer A; Kaffenberger SD; Chinnaiyan AM; Spratt DE; Montgomery J; Mehra R; Lew M
Diagn Cytopathol; 2019 May; 47(5):421-427. PubMed ID: 30569543
[TBL] [Abstract][Full Text] [Related]
17. Urine cytology findings in patients with biopsy-confirmed urothelial carcinoma in situ with plasmacytoid features.
Nichols MM; Reynolds JP; McKenney JK; Nicolas MM; McIntire PJ; Policarpio-Nicolas MLC
Cancer Cytopathol; 2021 Oct; 129(10):798-804. PubMed ID: 33900681
[TBL] [Abstract][Full Text] [Related]
18. Atypical urothelial tissue fragments in noninstrumented voided urine specimens are associated with low but significantly higher rates of urothelial neoplasia than benign-appearing urothelial tissue fragments.
Onur I; Rosenthal DL; VandenBussche CJ
Cancer Cytopathol; 2015 Mar; 123(3):186-92. PubMed ID: 25586692
[TBL] [Abstract][Full Text] [Related]
19. The Paris System for urine cytology in upper tract urothelial specimens: A comparative analysis with biopsy and surgical resection.
Zheng X; Si Q; Du D; Harshan M; Zhang Z; Haines K; Shi W; Chhieng DC
Cytopathology; 2018 Apr; 29(2):184-188. PubMed ID: 29251368
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of atypical urine cytology progression to malignancy.
Muus Ubago J; Mehta V; Wojcik EM; Barkan GA
Cancer Cytopathol; 2013 Jul; 121(7):387-91. PubMed ID: 23536358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
